Pricing Log in Create free account

ALX Oncology Holdings Inc. (ALXO) vs Oramed Pharmaceuticals Inc. (ORMP)

ALX Oncology Holdings Inc. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. ALX Oncology Holdings Inc. and Oramed Pharmaceuticals Inc. are of similar size ($160.6M and $159.7M). ALX Oncology Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Across the 13 metrics below, Oramed Pharmaceuticals Inc. leads on 10 and ALX Oncology Holdings Inc. on 3.

Valuation

Metric ALXO ORMP Biotechnology median
P/E n/m 0.91 10.60
P/S 64.54 39.40 9.40
P/B 1.16 0.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 13.96 26.81 9.02
Earnings yield (97.41%) 109.59% (32.88%)
Free cash flow yield (45.06%) (3.29%) (23.13%)

Profitability

Metric ALXO ORMP Biotechnology median
Gross margin 0.00% 32.31% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (80.65%) 73.90% (51.96%)
Return on assets (63.16%) 65.52% (46.06%)
Return on invested capital (673.30%) (3.40%) 0.00%

Growth

Metric ALXO ORMP Biotechnology median
Revenue growth (TTM) — 48.76% 6.76%
EPS growth (last fiscal year) 26.36% 412.50% 29.88%
Revenue growth, 5-year CAGR — (5.85%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALXO ORMP Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 9.71 4.98 4.97
Net debt to EBITDA 0.34 8.41 1.01

Dividend

Metric ALXO ORMP Biotechnology median
Dividend yield — 6.48% 0.41%
Payout ratio — 0.06 —

Size

Metric ALXO ORMP Biotechnology median
Market cap 159.71m 160.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack